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Acoustic overstimulation increases Ca2 concentration
in auditory hair cells. Because calcineurin is known to
activate cell death pathways and is controlled by Ca2
and calmodulin, this study assessed the role of cal-
cineurin in auditory hair cell death in guinea pigs after
intense noise exposure. Immediately after noise expo-
sure (4-kHz octave band, 120 dB, for 5 hr), a population
of hair cells exhibited calcineurin immunoreactivity at the
cuticular plate, with a decreasing number of positive-
stained cells on Days 1–3. By Day 7, the levels of cal-
cineurin immunoreactivity had diminished to near con-
trol, non-noise exposed values, concomitant with an
increasing loss of hair cells. Staining of hair cell nuclei
with propidium iodide (PI), restricted to calcineurin-
immunopositive cells, indicated breakdown of cell mem-
branes symptomatic of incipient cell death. The local
application of the calcineurin inhibitors, FK506 and cy-
closporin A, reduced the level of noise-induced auditory
brain stem response threshold shift and hair cell death,
indicating that calcineurin is a factor in noise-induced
hearing loss. The results suggest that calcineurin inhibi-
tors are of potential therapeutic value for long-term pro-
tection of the morphologic integrity and function of the
organ of Corti against noise trauma.
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Overexposure to intense sound can cause permanent
damage to the inner ear and hearing loss (Hawkins et al.,
1976). The structural changes underlying permanent
noise-induced hearing loss (NIHL) include loss of the
sensory hair cells of the inner ear and damage to their
stereocilia. Because hair cells do not regenerate in the
mammalian cochlea under normal conditions, loss of re-
ceptor cells and the associated hearing loss are irreversible
and cumulative. Cochlear neurons degenerate secondarily,
after the loss of sensory hair cells, suggesting that hair cells
should be the primary targets for therapeutic interventions
aiming to prevent hearing loss. In addition to direct noise-
induced mechanical destruction of cells of the inner ear,
oxidative stress associated with the formation of free rad-
icals (Yamane et al., 1995; Ohlemiller et al., 1999; Ohinata
et al., 2000) and excitotoxicity (Puel et al., 1998) are
factors contributing to the pathogenesis of hair cell and
hearing loss after noise trauma. Evidence from various cell
lines and in vivo neuronal and nonneuronal model systems
shows that cell death can be induced by oxidative stress
and excitotoxicity through Ca2 overload (Mattson,
2000; Aarts et al., 2003; Scorrano et al., 2003). Intracel-
lular Ca2 overload can cause cytotoxicity and trigger
apoptotic and necrotic cell death pathways (Orrenius et
al., 2003).
Acoustic overstimulation increases the [Ca2]i con-
centration in auditory hair cells (Fridberger et al., 1998;
Oliver et al., 2001). Elevated [Ca2]i has been implicated
in the impairment of hair cell function, may initiate hair
cell damage after noise exposure, and Ca2 blockers can
attenuate NIHL (Heinrich et al., 1999). There are a num-
ber of pathways through which Ca2 may contribute to
cell death, involving activation of nitric oxide synthase
(NOS) (Huang et al., 2002), phospholipase A2 (Caro and
Cederbaum, 2003), proteases (Kim et al., 2002), and cal-
cineurin (Jayaraman and Marks, 2000; Orrenius et al.,
2003). The role of calcineurin as a factor in NIHL has not
yet been assessed and is the focus of this report. Cal-
cineurin belongs to the family of Ca2/calmodulin-
dependent protein phosphatases, protein phosphatase 2B.
Calcineurin is activated by binding of Ca2/calmodulin
and is the only protein phosphatase that is regulated by a
second messenger, Ca2 (Morioka et al., 1999). Cal-
cineurin is involved in immune system responses (Kincaid,
1995), cardiac hypertrophy (Sussman et al., 1998), neuro-
nal and muscle development (Schiaffino and Serrano,
2002), the second messenger cAMP pathway (Antoni et
al., 1998), Na/K ion transportation (Tumlin, 1997), mem-
ory (Mansuy et al., 1998; Winder et al., 1998), and cell
Contract grant sponsor: NIH; Contract grant number: DC 04058; Contract
grant sponsor: General Motors Corporation; Contract grant sponsor: Ruth
and Lynn Townsend Professorship of Communication Disorders.
*Correspondence to: Josef M. Miller, PhD, Kresge Hearing Research
Institute, University of Michigan, 1301 E. Ann Street, Ann Arbor, MI
48109-0506. E-mail: josef@umich.edu
Received 19 May 2004; Revised 7 June 2004; Accepted 7 July 2004
Published online 27 August 2004 in Wiley InterScience (www.
interscience.wiley.com). DOI: 10.1002/jnr.20267
Journal of Neuroscience Research 78:383–392 (2004)
© 2004 Wiley-Liss, Inc.
death (Asai et al., 1999; Wang et al., 1999). FK506 and
cyclosporin A are calcineurin antagonists that are used
clinically in humans as immunosuppressors. They form
complexes with respective binding proteins, FKBP12
(FK506-binding protein) and cyclophilin A. These com-
plexes bind to a common composite surface made up of
residues from the catalytic subunit of calcineurin (Ke and
Huai, 2003), and in turn inhibit calcineurin activity.
We hypothesize that calcineurin activation plays a
role in NIHL. To test this hypothesis in the present study,
we: (1) assessed expression of calcineurin immunocyto-
chemically in hair cells after noise exposure; (2) evaluated
the relationship between calcineurin immunoreactivity
and cell viability, using propidium iodide (PI) to assess
incipient cell death; and (3) measured the effectiveness of
the calcineurin inhibitors FK506 and cyclosporin A to
attenuate noise trauma, as measured by noise-induced
threshold shift in the auditory brain stem response and
induced hair cell death. To the best of our knowledge, the
present work is the first evidence indicating that cal-
cineurin can be a significant factor in NIHL.
MATERIALS AND METHODS
Animals
Pigmented male guinea pigs (200–400 g, 2 weeks–4
weeks; Elm Hill Breeding Labs, Chelmsford, MA) were used in
this study. The experimental protocol was approved by the
Animal Care and Use Committee at the University of Michigan
and conforms to the National Institutes of Health Guidelines for
the Care and Use of Laboratory Animals.
Noise Exposure
Animals were exposed to one octave band noise (OBN)
centered at 4 kHz, at 120 dB SPL, for 5 hr in a ventilated sound
exposure chamber. The sound chamber was fitted with speakers
(Model 2450H; JBL) driven by a noise generator (ME
60 Micrographic equalizer; Rane) and power amplifier (HCA-
1000 high current power amplifier; Parasound Products). Sound
levels were calibrated (Type 2203 precision sound level meter,
Type 4134 microphone; Bruel and Kjar Instruments) at multiple
locations within the sound chamber to ensure uniformity of the
stimulus, using a fast Fourier transform network analyzer with a
linear scale. The stimulus intensity varied by a maximum of 3 dB
across measured sites within the exposure chamber. During
noise exposure, noise levels were monitored using a sound level
meter, a preamplifier, and a condenser microphone. The mi-
crophone was positioned within the cage at the level of the
animal’s head.
Immunocytochemistry for Calcineurin and
Rhodamine Phalloidin
Immunocytochemistry was carried out in animals not
receiving any treatment and in animals at 4 time points (imme-
diate, Day 1, 3, and 7) after noise exposure (n  3 each).
Animals were anesthetized deeply with ketamine (40 mg/kg,
intramuscularly) and xylazine (10 mg/kg, intramuscularly) and
the temporal bones removed and transferred into 4% parafor-
maldehyde in phosphate-buffered saline (PBS). Under a dissect-
ing microscope, the round and oval windows and the bone near
the apex were opened, followed by gentle local perfusion from
the apex. The tissue was kept in the fixative for overnight. After
PBS rinses and removal of the bony capsule and the lateral wall
tissues, the modiolar core including the organ of Corti was
removed from the temporal bone. Tissue was incubated in
blocking solution consisting of 3% normal goat serum (Anti-
bodies Incorporated, Davis, CA) in 0.3% Triton X-100 in PBS
for 30 min. The organ of Corti was stained with monoclonal
anti-calcineurin antibody (1:100; BD Bioscience Pharmingen,
San Diego, CA) overnight at 4°C. Samples were washed three
times in PBS and then incubated for 1 hr in a 1:200 dilution of
Alexa Fluor 488-conjugated goat anti-mouse IgG secondary
antibody (Molecular Probes, Eugene, OR). Tissue were then
washed three times with PBS and incubated with a 1:100
dilution of rhodamine phalloidin (Molecular Probes) for 40 min
to outline hair cells and their stereocilia. After three PBS rinses,
the organ of Corti was dissected and mounted as a surface
preparation. Immunolabeling was visualized using Olympus FV-
500 confocal microscope. Sections for immunocytochemical
assessment were taken from an area approximately 10 mm from
the apex.
PI Staining and Immunocytochemistry for Calcineurin
and Coumarin Phallacidin
Animals were sacrificed immediately after noise exposure
(n  3) under deep xylazine and ketamine anesthesia. Temporal
bones were removed, transferred into 5 g/ml PI (Molecular
Probes) in Hanks’ balanced salt solution (HBSS) (Invitrogen),
and perfused carefully with PI as above. The tissues were incu-
bated with PI solution for 15 min, washed with gentle local
perfusion of HBSS, fixed by local perfusion of 4% paraformal-
dehyde in PBS, and then incubated overnight. The same regi-
men of immunocytochemistry was followed as before, except
that coumarin phallacidin was used instead of rhodamine
phalloidin.
FK506 and Cyclosporin A Cochlear Infusions
Additional experiments were designed to determine
whether local application of the calcineurin inhibitors FK506, at
concentration of 0.01 (n  6), 0.1 (n  6), 1 (n  8), or 10
(n  8) g/ml, or cyclosporin A (10 g/ml; n  7), into the
scala tympani could rescue the cochlea from noise-induced
damage. FK506, cyclosporin A, or artificial perilymph (AP) (n 
8) was infused into the left cochlea via an osmotic pump/
cannula system over 14 days initiated 4 days before noise expo-
sure and continuing until sacrifice.
Alzet mini-osmotic pumps (model 2002, 0.5 l/hr for
14 days; Alza Corp., Palo Alto, CA) were filled with treatment
solution FK506 (Prograf; Fujisawa Healthcare, Deerfield, IL) or
cyclosporin A (Sandimmune; Novartis, Basel, Switzerland) di-
luted in AP (sterile normal Ringer’s solution, pH 7.34, osmotic
pressure 285 mOsm/L, NaCl 145 mM, KCl 2.7 mM, MgSO4
2.0 mM, CaCl2 1.2 mM, and HEPES, C8H18N2O4S, 5.0 mM).
Animals were anesthetized with ketamine/xylazine, and surgical
procedures for cochlea microcannulation and osmotic pump
implantation were carried out as described in Prieskorn and
Miller (2000).
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To allow time for recovery from surgery, the pump/
cannula was implanted 4 days before noise exposure. Auditory
brainstem response (ABR) was assessed bilaterally 3–7 days
before surgery, to assure normal hearing, and on Day 3 after
implant surgery, to assure the absence of surgical-induced inner
ear damage. Those subjects showing no surgery-induced thresh-
old shift were exposed to noise. ABRs were reassessed 10 days
after noise exposure. On the following day the animal was
sacrificed, and the middle ear space, cannula tip placement, and
cannula/pump connection were examined carefully, after which
both cochleae were removed. Any animal with postsurgical
hearing loss, middle ear problem, or cannula/pump malfunction
was excluded from the study. Ears were then processed for
histologic assessment.
Auditory Brainstem Responses
To establish baseline auditory thresholds, animals were
anesthetized deeply with xylazine and ketamine. A differential
active needle electrode was placed subcutaneously below the test
ear, a reference electrode at the vertex, and a ground electrode
below the contralateral ear. The sound stimulus consisted of
15-msec tone bursts, with a rise-fall time of 1 msec at frequen-
cies of 4, 8, and 16 kHz, generated by a Fordham Audio
Generator (Model AG-298; Fordham Radio Supply, Haup-
pauge, NY). The stimuli were presented to the external auditory
meatus in a closed acoustic system through a tube connected to
a transducer (Beyer DT-48; Beyer Dynamic, Farmingdale, NY).
Auditory brain stem responses were elicited by tone presenta-
tions delivered at 10/sec. The responses to 1,024 presentations
were averaged using a Tucker-David data aquisition system with
computer and custom software. The resulting ABR wave traces
were displayed on an oscilloscope and visually evaluated. Hear-
ing threshold was defined as the lowest stimulus intensity at
which a repeatable wave form (with clearly identifiable peaks 3
and 4) was obtained.
Cytocochleogram
After fixation with 4% paraformaldehyde in PBS, the
modiolar core including the organ of Corti was removed from
the temporal bone. After permeabilization with 0.3% Triton
X-100 for 30 min, the organ of Corti was stained for F-actin
with a 1:100 dilution of rhodamine phalloidin for 40 min to
outline hair cells and their stereocilia for a quantitative assess-
ment. After being washed with PBS, the organ of Corti was
dissected and mounted as surface preparations. Tissues were
observed under fluorescence microscopy and the number of
missing inner and outer hair cells (IHC and OHC, respectively)
was counted from the apex to the base in 0.19-mm sections.
Missing hair cells were apparent as dark spots or the typical
phalangeal scar of supporting cells. Counting was begun
0.95 mm from the apex, omitting the irregular apical part of the
cochlear spiral. Percentages of hair cell loss in each 0.19-mm
length of tissue were plotted along the cochlear length as a
cytocochleogram. The region of greatest damage from 4-kHz
centered OBN, as demonstrated in this and previous studies
(Shoji et al., 2000; Yamashita et al., 2003, 2004), was
8.93–13.11 mm from the apex. Differences in this region were
evaluated for statistical significance.
Statistical Analysis
All values are presented as mean  standard error of the
mean (SEM). Differences among the different groups were
evaluated using one-way analysis of variance (ANOVA) fol-
lowed by Student-Newman-Keul’s as a post-hoc test. Addition-
ally, differences between the treated (left) ears and untreated
(right) ears in each group were assessed using an unpaired
Student’s t-test. P  0.05 was considered significant.
RESULTS
Noise Increases Calcineurin Immunoreactivity in
Outer Hair Cells (OHCs)
Immunohistochemistry was used to assess hair cell
loss and expression of calcineurin after noise exposure. For
the assessment of calcineurin, measures were taken at five
time points: no noise exposure, immediately after expo-
sure, and 1, 3, and 7 days after exposure.
As shown in Figure 1A, in a representative surface
preparation of unexposed control tissue the organ of Corti
showed normal cellular architecture and no calcineurin
staining in hair cells. After noise exposure, varying degrees
of hair cell loss and calcineurin immunoreactivity were
present in outer hair cells, depending on the time after
exposure. Tissue from animals sacrificed immediately after
noise exposure (Fig. 1B) showed the greatest numbers of
calcineurin-immunopositive hair cells, with decreasing
numbers of positive-staining cell on Days 1–3 (Fig. 1C,D).
By Day 7 (Fig. 1E), the levels of calcineurin immunore-
activity had diminished to near control, non-noise ex-
posed values. We observed no calcineurin staining in inner
hair cells at any time points, and no specific staining in
other types of cells on the surface preparation. Sections
were taken approximately 10 mm from the apex.
Calcineurin Is Associated With Dying Hair Cells
To determine whether calcineurin-immunopositive
hair cells were in fact dying, PI staining of hair cell nuclei
was used to indicate cell membrane breakdown, symp-
tomatic of incipient cell death. Figure 2 (A–I) shows a
representative surface preparation of cochlear tissue taken
immediately after noise exposure showing observations at
nine depths of focus, descending from the cuticular plate
(Fig. 2A) to the nuclear region (Fig. 2I), with a distance of
1 m between images. After noise exposure, calcineurin
seems concentrated at the cuticular plate. PI staining is
restricted to calcineurin-positive cells (Fig. 2J). Some
calcineurin-immunopositive hair cells demonstrated con-
densed nuclei (Fig. 2I, arrow), and some showed swollen
nuclei (Fig. 2I, arrowhead), indicating that calcineurin is
related to both apoptosis and necrosis.
Calcineurin Inhibitors FK506 and Cyclosporin A
Reduce NIHL
Of 43 guinea pigs that underwent left ear surgery for
microcannulation/pump-implantation, 9 animals were ex-
cluded from the study due to postsurgical hearing loss (4),
middle ear infection (4), or a disconnected pump (1). In
total, 34 subjects were used for data analysis: 6 received
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AP; 4 FK506 (0.01 g/ml); 5 FK506 (0.1 g/ml); 7
FK506 (1 g/ml); 7 FK506 (10 g/ml); and 5 cyclosporin
A (10 g/ml). Figure 3A illustrates ABR threshold shifts
for each group at each frequency on Day 10 after noise
exposure for the treated side (left ears). Treatment with
FK506 demonstrated a dose-dependent attenuation of
noise-induced ABR threshold shifts. Ears treated with 1 or
10 g/ml FK506 or 10 g/ml cyclosporin A showed
significantly smaller threshold shifts at each frequency
compared to that of the AP-treated ears. Concentrations
of 0.01 and 0.1 g/ml of FK506 were insufficient to
produce a statistically significant attenuation. The efficacy
of FK506 was saturated at 1 g/ml for all frequencies. The
left cochleae, perfused with 1 (Fig. 3E) or 10 (Fig. 3F)
g/ml FK506 or 10 g/ml cyclosporin A (Fig. 3G),
demonstrated a significantly smaller ABR threshold shift
than the untreated right cochleae. In contrast, left cochleae
perfused with AP (Fig. 3B), 0.01 g/ml FK506 (Fig. 3C),
or 0.1 g/ml FK506 (Fig. 3D) showed no significant
differences compared to the untreated right cochleae.
Calcineurin Inhibitors FK506 and Cyclosporin A
Reduce Noise-Induced Hair Cell Loss
The number of preserved and missing hair cells was
assessed at 10 days after noise exposure, after final ABR
recordings. Cytocochleograms (Fig. 4) illustrate the aver-
age percentage of missing OHCs along the organ of Corti
for each group. Hair cell loss was significantly reduced by
1 and 10 g/ml of FK506 and 10 g/ml cyclosporin A,
whereas 0.01 and 0.1 g/ml FK506 showed a statistically
insignificant tendency to reduce hair cell loss (Fig. 4A–E).
OHC damage was reduced by 82% (1 g/ml FK506),
82% (10 g/ml FK506), and 78% (10 g/ml cyclosporin
A) compared to that in AP controls.
Figure 5 shows the mean percentage ( SEM) miss-
ing OHC at 8.93–13.11 mm from the apex. Results from
the groups treated with FK506 at 1 and 10 g/ml and
10 g/ml cyclosporin A were significantly different from
those of the AP treated group (Fig. 5A). FK506 demon-
strated a clear dose-dependent efficacy in the attenuation
of noise-induced OHC loss. With increasing concentra-
tion of FK506, OHC loss was reduced from approxi-
mately 60% observed with AP to a 10% loss with
10 g/ml FK506. Although left cochleae perfused with 1
Š
Fig. 1. Hair cell loss and calcineurin immunoreactivity in noise ex-
posed cochlea. Confocal images of anti-calcineurin (green) and rho-
damin phalloidin (red) double-labeled surface preparation. Sections
were taken approximately 10 mm from apex, which is the area known
to be damaged by 4-kHz OBN. Tissue were taken at time intervals
from no noise exposure (A), to immediately after exposure (B), and 1
(C), 3 (D), and 7 days (E) after noise exposure. No calcineurin staining
was seen in normal hair cells of nonexposed cochlea (A). Immediately
after noise exposure, green calcineurin immunoreactivity was present in
some OHCs (B), with decreasing numbers of positive-staining cell on
Days 1–3 (C, D). On Day 7 (E), the levels of calcineurin immunore-
activity were most diminished, concomitant with an increasing loss of
hair cells.
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(Fig. 5E) or 10 g/ml FK506 (Fig. 5F) or 10 g/ml
cyclosporin A (Fig. 5G) showed significantly smaller OHC
loss than did the contralateral untreated cochleae, those
cochleae treated with AP (Fig. 5B), 0.01 g/ml (Fig. 5C),
and 0.1 g/ml FK506 (Fig. 5D) showed no significant
differences between treated and untreated cochleae.
DISCUSSION
After noise exposure, calcineurin immunoreactivity
was observed in hair cells in the region approximately
10 mm from the apex of the cochlea, which is the region
maximally damaged by 4 kHz OBN (Tsuji and Liberman,
1997; Ohinata et al., 2000; Shoji et al., 2000). Tissue
from animals sacrificed immediately after noise exposure
showed the greatest number of calcineurin-immuno-
positive hair cells, indicating that calcineurin is an early
response to noise stress. On Days 1–3, the number of
calcineurin-immunopositive hair cells had decreased, and
by Day 7, the level of calcineurin immunoreactivity in hair
cells had diminished to near control levels. Because the
rate of hair cell loss was the greatest immediately after
noise exposure and decreased over succeeding days (Ya-
mashita et al., 2003, 2004), the distribution of calcineurin-
immunopositive hair cells may parallel the rate of hair cell
loss, i.e., those cells expressing calcineurin may die. Care-
ful assessment at a range of depths from the cuticular plate
to the nuclear region indicated that calcineurin concen-
trated at the cuticular plate. It is not clear if the calcineurin
immunoreactivity results from expression or localization
of calcineurin. Expression of calcineurin is induced by
insulin-like growth factor (IGF)-I (Musaro et al., 1999;
Fig. 2. Calcineurin is associated with dying OHCs. One surface prep-
aration of cochlea tissue taken immediately after noise exposure and
triple labeled for calcineurin (green), coumarin phallacidin (blue), and
PI (red) is shown at nine depths of focus (A–I), descending from the
cuticular plate (A) to the nuclear region (I) in increments of 1 m. Note
that calcineurin seemed to concentrate at the cuticular plate region, and
that OHCs exhibiting calcineurin immunoreactivity at the cuticular
plate show PI penetration of nuclei, in which some are condensed
(arrow) and others are swollen (arrowhead). J: Simplified diagram of
the cuticular and nucleus regions of this section.
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Gooch et al., 2001) or tumor growth factor (TGF)
(Gooch et al., 2004), and localization of calcineurin is
determined by various anchoring proteins regulating cal-
cineurin physiologic activity (Dodge and Scott, 2003). At
postsynaptic dendrites, calcineurin interacts with A kinase-
anchoring protein (AKAP79/150) and is localized to the
cell membrane (Oliveria et al., 2003). This complex in
turn modulates actin remodeling (Gomez et al., 2002). It
is not known if these proteins are present in hair cells or if
they are influenced by noise.
Supporting the suggestion that cells expressing cal-
cineurin immunoreactivity may die, hair cells demonstrat-
ing calcineurin immunoreactivity also showed PI labeling.
Because PI is membrane impermeable and generally ex-
cluded from viable cells, PI is used to identify nuclei of
dying cells in a population. PI staining was restricted to
calcineurin-immunopositive hair cells, indicating that cal-
cineurin immunoreactivity is associated with hair cell
death. Nuclear condensation and shrinkage are typical
morphologies of apoptosis, whereas nuclear swelling is a
feature of necrosis. After noise exposure, both apoptotic
and necrotic nuclei were observed in hair cells demon-
strating co-labeling for calcineurin and PI. These findings
support previous studies reporting that noise-induced hair
cell death involves mechanisms of both apoptosis and
necrosis (Hu et al., 2002; Wang et al., 2002).
There are a variety of biochemical cascades induced
by calcineurin that may lead to apoptotic and necrotic cell
death. Calcineurin dephosphorylates NOS (Dawson et al.,
1993) leading to nitric oxide-induced cell death pathways.
Calcineurin also dephosphorylates the Bcl-2 family pro-
tein BAD (Wang et al., 1999), which activates apoptotic
death pathways; and calcineurin may inactivate Bcl-2
(Erin et al., 2003a,b), an antiapoptotic protein. Cal-
cineurin is cleaved directly by calpain and overexpression
of cleaved calcineurin can induce caspase activity and
neuronal cell death (Wu et al., 2004). Moreover, cal-
cineurin is also involved in oxidative stress-induced cell
death (See and Loeffler, 2001; Mbebi et al., 2002). Most of
these pathways require the activation of calcineurin. It was
therefore of interest to determine whether the calcineurin
inhibitors would protect hair cells against acoustic trauma.
The observation that the calcineurin inhibitors
FK506 and cyclosporin A attenuate noise-induced hearing
loss and hair cell loss indicates that the activation of cal-
cineurin is important in NIHL. Although a contralateral
effect has been reported with high concentrations of pro-
tective agent in other studies involving local application of
Fig. 3. Local delivery of the calcineurin
inhibitor FK506 and cyclosporin A into
the cochlea attenuates NIHL. Hearing
threshold shifts were assessed by auditory
brainstem testing at 4, 8, and 16 kHz, 10
days after noise exposure of AP- (n  6),
FK506- (n  4 at 0.01, n  5 at 0.1, n 
7 at 1, and n  7 at 10 g/ml), and
cyclosporin A-treated (n  5) guinea
pigs. Changes in hearing thresholds are
expressed as mean values  SEM. Note
the dose-dependent efficacy of FK506.
A: The average threshold shifts in AP-
treated animals were significantly greater
than were those of 1 and 10 g/ml
FK506-and 10 g/ml cyclosporin
A-treated ears, but there were no signif-
icant effects for 0.01 and 0.1 g/ml
FK506. B–G: Comparisons: AP- (B),
0.01 (C), 0.1 (D), 1 (E), and 10 g/ml
FK506- (F) and 10 g/ml cyclosporin
A- (G) treated left cochleae (white dia-
mond) with contralateral untreated right
cochleae (black diamond) in the same
animals exposed to acoustic trauma. Left
cochleae treated with 1 and 10 g/ml
FK506 and 10 g/ml cyclosporin A
showed significantly smaller ABR
threshold shifts than did the contralateral
untreated cochleae. Cochleae infused
with AP, 0.01 g/ml FK506, or
0.1 g/ml FK506, however, showed no
significant differences compared to the
contralateral untreated cochlea.
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drugs to the scala tympani of the guinea pig (Shoji et al.,
2000), we observed no contralateral effect in this study.
FK506 and cyclosporin A are immunosuppressants are
used widely in organ transplantation for prevention of
allograft rejection (Nabel, 1999). Systemic application may
therefore have unwanted side effects that may be avoided
by intracochlear perfusion by osmotic pump. The use of
an osmotic pumps also allows relatively precise control
over the timing and concentration of drugs applied to the
tissues of the inner ear.
These drugs exert their effects via immunophilins,
the protein receptors for these agents. Broadly speaking,
there are two categories of immunophilins: the FK506
binding proteins (FKBPs), which bind FK506, and the
cyclophilins, which bind cyclosporin A. Currently, the
best characterized immunophilins are FKBP12 and cyclo-
philin A, whose complexes with FK506 and cyclosporin
A, respectively, inhibit calcineurin activity. Depending on
the immunophilins to which FK506 and cyclosporin A
bind, FK506 and cyclosporin A have other functions in
addition to calcineurin inhibition. When cyclosporin A
binds to cyclophilin D, cyclosporin A can stabilize
mitochondrial membranes and block mitochondrial
permeability transition (MPT) (Lin and Lechleiter, 2002),
and FKBP52 mediates the neurotrophic action of FK506
(Gold et al., 1999). The observation that both FK506 and
cyclosporin A reduce NIHL, however, suggests that cal-
cineurin inhibition is the important feature of the mech-
anism of FK506- and cyclosporin A-induced protection
against noise trauma. The fact that FK506 and cyclosporin
A are used clinically in humans supports the potential
value of these agents to attenuate NIHL in humans.
A putative cause for noise-induced hair cell death, in
addition to the initial death, caused by pure mechanical
damage, is impaired cochlear metabolism and oxidative
stress. Noise induces reactive oxygen species (ROS) for-
mation (Ohinata et al., 2000); ROS scavengers and inhib-
itors have been implicated in protection against NIHL
(Yamasoba et al., 1999; Hou et al., 2003; Ohinata et al.,
2003). A preliminary experiment of a combination treat-
ment consisting of FK506 and the ROS scavenger Trolox
(vitamin E) showed no significant difference in effective-
ness than with either drug alone, i.e., noise-induced ROS
production and activation of calcineurin may thus be
connected. Ca2 influx may mediate both actions, be-
cause oxidative stress is known to both cause and be
exacerbated by [Ca2]i overload (Mattson, 2000; Aarts et
al., 2003; Scorrano et al., 2003). Interestingly, in vitro
calcineurin inhibitors have been shown to prevent loss of
neuronal cells after exposure to H2O2 (See and Loeffler,
2001) and -amyloid precursor protein (Mbebi et al.,
2002), each of which causes oxidative stress, calcineurin
activation, and neuronal cell death. Taken together, these
data implicate calcineurin activity as an important pathway
in stress-induced cell death and support further the ther-
Fig. 4. Local delivery of the calcineurin inhibitor FK506 and cyclo-
sporin A into the cochlea attenuates intense noise-induced hair loss.
A–E: Cytocochleogram of cochleae treated with 0.01 (n  4; A), 0.1
(n  4; B), 1 (n  6; C), or 10 g/ml FK506 (n  5; D) or 10 g/ml
cyclosporin A (n  5; E) (gray line) compared to cochleae treated with
AP (n  6; black line). The mean percentage ( SEM) of missing
OHCs in AP-treated ears was 27  6%. Hair cell protection was
observed to be dose-dependent with hair cell loss decreasing from 20 
8%, to 14  5%, to 5  2%, and finally to 5  1%, with increasing
concentrations of FK506 (from 0.01, to 0.1, to 1, to 10 g/ml).
Noise-induced hair cell loss was reduced by 1 or 10 g/ml FK506, as
well as 10 g/ml cyclosporin A (6  1%), whereas 0.01 and 0.1 g/ml
FK506 did not reach statistical efficacy.
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apeutic potential of FK506 and cyclosporin A in nonneu-
ronal and neuronal models of oxidative stress.
In summary, we have reported three interesting find-
ings: (1) acoustic overstimulation induces calcineurin im-
munoreactivity at the cuticular plate region in auditory
hair cells; (2) nuclei of calcineurin-positive hair cells stain
with PI, which indicates dying cells; and (3) the cal-
cineurin inhibitors FK506 and cyclosporin A reduce
NIHL. These observations suggest that calcineurin is a
factor in noise-induced hair cell death, and calcineurin
Fig. 5. FK506 and cyclosporin A reduced noise-induced hair cell loss
at 8.93–13.11 mm from apex. The mean percentage (SEM) of
missing OHCs at 8.93–13.11 mm from apex was calculated for each
group (n  6 for AP, n  4 for 0.01 g/ml FK506, n  4 for
0.1 g/ml FK506, n  6 for 1 g/ml FK506, n  5 for 10 g/ml
FK506, and n  5 for 10 g/ml cyclosporin A. A: FK506 at 1 and
10 g/ml and 10 g/ml cyclosporin A were significantly different from
the AP-treated group. B–G: Comparisons of left cochleae perfused
with AP (B), 0.01 (C), 0.1 (D), 1 (E), and 10 g/ml FK506 (F) and
10 g/ml cyclosporin A (G) and contralateral unperfused cochleae. Left
cochleae treated with 1 and 10 g/ml FK506 and 10 g/ml cyclo-
sporin A showed significantly reduced noise-induced hair cell loss as
compared to that in the untreated right cochleae. Left cochleae treated
with AP, 0.01, and 0.1 FK506, however, showed no significant differ-
ences compared to the untreated right cochleae.
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inhibitors may have potential clinical value to reduce
NIHL.
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